Skip to main content
NanoVibronix, Inc. logo

NanoVibronix, Inc. — Investor Relations & Filings

Ticker · NAOV ISIN · US63008J7028 LEI · 5493008114LTFZQ2I595 US Manufacturing
Open in API
Filings indexed 512 across all filing types
Latest filing 2020-12-23 Director's Dealing
Country US United States of America
Listing US NAOV

About NanoVibronix, Inc.

https://nanovibronix.com/

NanoVibronix, Inc. is a medical technology company that develops non-invasive and minimally invasive biological response-activating devices. The company's core technology is based on a proprietary, patented low-intensity surface acoustic wave (SAW) ultrasound. Its main products include PainShield®, a portable device for pain therapy and the treatment of nerve and soft tissue damage, and UroShield®, an ultrasound device designed to prevent bacterial biofilm on urinary catheters. These prescription-based products offer therapeutic alternatives to medication for pain management, wound healing, and biofilm prevention, targeting both clinical and home care settings.

Recent filings

Filing Released Lang Actions
4 Filing
Director's Dealing
2020-12-23 English
Capital/Financing Update 2020
Capital/Financing Update Classification · 100% confidence The document is a detailed prospectus filed pursuant to Rule 424(b)(3) under the Securities Act of 1933. It describes the offering and resale of common stock shares by selling stockholders, including details about private placements, warrants, and registration rights. The document includes sections such as "Risk Factors," "Use of Proceeds," "Selling Stockholders," and "Plan of Distribution." It is clearly a registration prospectus related to capital raising and share resale activities, not a financial report, earnings release, or management discussion. The presence of terms like "prospectus," "registration statement," and detailed share offering information indicates this is a Capital/Financing Update filing. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2020-12-16 English
Regulatory Filings 2020
Regulatory Filings
2020-12-16 English
Regulatory Filings 2020
Regulatory Filings Classification · 95% confidence The document is a letter from NanoVibronix, Inc. to the SEC requesting acceleration of the effective date of a Registration Statement on Form S-3. It references a filing (Form S-3) and requests an administrative action (acceleration). The document is short (1381 characters) and is a correspondence related to a regulatory filing, not the filing itself. There is no financial data or report content. This fits the category of Regulatory Filings (RNS), which includes correspondence and miscellaneous filings that do not fit other categories.
2020-12-15 English
Capital/Financing Update 2020
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text specifically discusses a Nasdaq listing compliance issue and a private placement financing completed by the company to meet listing requirements. It is not a full financial report but an announcement of a financing event and compliance status. The document length is 3681 characters, which is relatively short and consistent with an 8-K filing. The content focuses on capital raising and Nasdaq listing compliance, which aligns with a Capital/Financing Update rather than an Annual Report, Earnings Release, or other categories. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2020-12-14 English
Capital/Financing Update 2020
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement (an amended and restated distribution agreement) and includes details about the terms and conditions of this agreement. It also references a press release attached as an exhibit. There are no financial statements or comprehensive financial data presented, nor is this an earnings release or annual/interim report. The document is clearly an announcement of a significant corporate event related to a material contract. According to the filing definitions, this fits best under Capital/Financing Update (CAP) because it involves a material definitive agreement affecting the company's business and revenue targets, which is typical for financing or capital-related updates. The document is not a report publication announcement or regulatory filing fallback since it contains substantive information about the agreement itself.
2020-12-14 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.